The status of dialysis patients in Asian countries under the coronavirus disease 2019 (COVID-19) disaster as of December 2019–June 2023: India
Authors:
Open Access
- 8 November 2024
- journal article
- review article
- Published by Springer Nature in Renal Replacement Therapy
- Vol. 10 (1) , 1-8
Abstract
The coronavirus disease 2019 (COVID-19) pandemic affected the entire world with unprecedented impact on the health care and economy of countries. India, the most populous country, faced enormous challenges across its diverse population groups. The end-stage renal disease (ESRD) patients on dialysis, especially hemodialysis, were a high-risk group with inevitable regular hospital visits in contrast to the home peritoneal dialysis group. The unplanned lockdown and home confinement posed many risks to dialysis patients due to dialysis unit closures, logistical issues, and severe COVID-19-related morbidities. We have paucity of data on mortality of dialysis patients in India. We describe the reported and available data on COVID-19 in India from across different centers. The vaccination provided by two different pharmaceuticals such as Covaxin and Covishield in a small cohort of dialysis patients reduced infection and severity.Keywords
This publication has 14 references indexed in Scilit:
- SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance DialysisAmerican Journal of Kidney Diseases, 2022
- Present status of renal replacement therapy in lower-middle-income Asian countries: Cambodia, Myanmar, Laos, Vietnam, Mongolia, and Bhutan as of June 2019 (before COVID-19), from the interviews of leading doctors in every country: (duplicated English publication from “the special Japanese edition of educational lectures in the 64th annual meeting of the Japanese Society for Dialysis Therapy”)Renal Replacement Therapy, 2022
- Current status of renal replacement therapy in Cambodia and Japanese support activities in developing countries in East and Southeast Asia: a report as of June 2018 from the Non-Western World Countries Symposium at the 63rd Annual Meeting of the Japanese Society for Dialysis TherapyRenal Replacement Therapy, 2022
- The High Mortality and Impact of Vaccination on COVID-19 in Hemodialysis Population in India During the Second WaveKidney International Reports, 2021
- Outcome and Determinants of Outcome of COVID-19 Infection Among Hemodialysis Patients: Findings From a National Dialysis Network Program in IndiaKidney International Reports, 2021
- Present status of renal replacement therapy in Asian countries as of 2017: Vietnam, Myanmar, and CambodiaRenal Replacement Therapy, 2020
- The Adverse Effect of COVID Pandemic on the Care of Patients With Kidney Diseases in IndiaKidney International Reports, 2020
- Present status of renal replacement therapy in Asian countries as of 2016: Cambodia, Laos, Mongolia, Bhutan, and IndonesiaRenal Replacement Therapy, 2019
- Present status of renal replacement therapy at 2015 in Asian countries (Myanmar, Vietnam, Thailand, China, and Japan)Renal Replacement Therapy, 2017
- Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional studyThe Lancet Global Health, 2016